Stephen Fair brings nearly two decades of strategic finance and operational leadership across discovery-focused biotech and pharmaceutical companies. Most recently, he served as Senior Vice President of Finance at Abata Therapeutics, where he led financial strategy and operations. He previously held senior finance roles at FogPharma, Agios Pharmaceuticals and Merrimack Pharmaceuticals. Stephen earned his B.A. in Economics from Yale University and his MBA from Stanford University.